Viewing Study NCT01054118


Ignite Creation Date: 2025-12-25 @ 5:00 AM
Ignite Modification Date: 2026-01-05 @ 3:47 PM
Study NCT ID: NCT01054118
Status: COMPLETED
Last Update Posted: 2013-09-04
First Post: 2010-01-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Doses of JNJ-38431055, Sitagliptin, and Co-administration of JNJ-38431055 and Sitagliptin
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module